Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
804,881
-
Share change
-
+15,730
-
Total reported value
-
$162,715,551
-
Put/Call ratio
-
134%
-
Price per share
-
$202.13
-
Number of holders
-
118
-
Value change
-
+$3,193,694
-
Number of buys
-
48
-
Number of sells
-
33
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2021
As of 30 Sep 2021 VANECK ETF TRUST - BIOTECH ETF (BBH) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 804,881 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ROYAL BANK OF CANADA, UBS Group AG, LPL Financial LLC, MURPHY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, Kestra Advisory Services, LLC, and STIFEL FINANCIAL CORP.
This table shows 118 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.